Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic
Objective: To evaluate how the restrictive measures implemented during the SARS-CoV-2 pandemic have influenced the incidence of the most common children’s diseases and the consumption of medications in 2020 compared to 2019. Methods: We involved all family pediatricians of the local health authority...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/8/12/1183 |
_version_ | 1827673411790307328 |
---|---|
author | Riccardo Lubrano Emanuela Del Giudice Alessia Marcellino Flavia Ventriglia Anna Dilillo Enrica De Luca Saverio Mallardo Sara Isoldi Vanessa Martucci Mariateresa Sanseviero Donatella Iorfida Concetta Malvaso Giovanni Cerimoniale Giuseppina Ragni Anna Lisa Grandinetti Loredana Arenare Silvia Bloise |
author_facet | Riccardo Lubrano Emanuela Del Giudice Alessia Marcellino Flavia Ventriglia Anna Dilillo Enrica De Luca Saverio Mallardo Sara Isoldi Vanessa Martucci Mariateresa Sanseviero Donatella Iorfida Concetta Malvaso Giovanni Cerimoniale Giuseppina Ragni Anna Lisa Grandinetti Loredana Arenare Silvia Bloise |
author_sort | Riccardo Lubrano |
collection | DOAJ |
description | Objective: To evaluate how the restrictive measures implemented during the SARS-CoV-2 pandemic have influenced the incidence of the most common children’s diseases and the consumption of medications in 2020 compared to 2019. Methods: We involved all family pediatricians of the local health authority of Latina, from which we requested data of monthly visits in 2019 and 2020 for six common diseases disseminated through droplets and contact, and the territorial and integrative pharmaceutical unit of the area, from which we requested data of the net expenditure regarding the most commonly used drugs at pediatric age. Results: There was significant reduction in the incidence of the evaluated diseases and in the consumption of investigated drugs between 2019 and 2020 in the months when the restrictive measures were in place, with an attenuation of this effect during the months of the gradual loosening of those measures. Conclusion: Nonpharmaceutical intervention measures have caused changes in the diffusion of common pediatric diseases. We believe that the implementation of a reasonable containment strategy, even outside of the pandemic, could positively influence the epidemiology of infectious and allergic diseases in children, and healthcare system spending. |
first_indexed | 2024-03-10T04:23:28Z |
format | Article |
id | doaj.art-03b69d0755e2490e9a9e289309936205 |
institution | Directory Open Access Journal |
issn | 2227-9067 |
language | English |
last_indexed | 2024-03-10T04:23:28Z |
publishDate | 2021-12-01 |
publisher | MDPI AG |
record_format | Article |
series | Children |
spelling | doaj.art-03b69d0755e2490e9a9e2893099362052023-11-23T07:43:04ZengMDPI AGChildren2227-90672021-12-01812118310.3390/children8121183Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 PandemicRiccardo Lubrano0Emanuela Del Giudice1Alessia Marcellino2Flavia Ventriglia3Anna Dilillo4Enrica De Luca5Saverio Mallardo6Sara Isoldi7Vanessa Martucci8Mariateresa Sanseviero9Donatella Iorfida10Concetta Malvaso11Giovanni Cerimoniale12Giuseppina Ragni13Anna Lisa Grandinetti14Loredana Arenare15Silvia Bloise16Dipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyPediatri di Famiglia Azienda Sanitaria Locale di Latina, 04100 Latina, ItalyPediatri di Famiglia Azienda Sanitaria Locale di Latina, 04100 Latina, ItalyPediatri di Famiglia Azienda Sanitaria Locale di Latina, 04100 Latina, ItalyDirezione Sanitaria Azienda Sanitaria Locale di Latina, 04100 Latina, ItalyUOC Farmaceutica Territoriale e Integrativa Azienda Sanitaria Locale di Latina, 04100 Latina, ItalyDipartimento Materno Infantile e di Scienze Urologiche, Sapienza Università di Roma, UOC di Pediatria e Neonatologia–Polo Pontino, 04100 Latina, ItalyObjective: To evaluate how the restrictive measures implemented during the SARS-CoV-2 pandemic have influenced the incidence of the most common children’s diseases and the consumption of medications in 2020 compared to 2019. Methods: We involved all family pediatricians of the local health authority of Latina, from which we requested data of monthly visits in 2019 and 2020 for six common diseases disseminated through droplets and contact, and the territorial and integrative pharmaceutical unit of the area, from which we requested data of the net expenditure regarding the most commonly used drugs at pediatric age. Results: There was significant reduction in the incidence of the evaluated diseases and in the consumption of investigated drugs between 2019 and 2020 in the months when the restrictive measures were in place, with an attenuation of this effect during the months of the gradual loosening of those measures. Conclusion: Nonpharmaceutical intervention measures have caused changes in the diffusion of common pediatric diseases. We believe that the implementation of a reasonable containment strategy, even outside of the pandemic, could positively influence the epidemiology of infectious and allergic diseases in children, and healthcare system spending.https://www.mdpi.com/2227-9067/8/12/1183preventive measureschildreninfectious diseasesdrugspediatric and healthcareexpenditure |
spellingShingle | Riccardo Lubrano Emanuela Del Giudice Alessia Marcellino Flavia Ventriglia Anna Dilillo Enrica De Luca Saverio Mallardo Sara Isoldi Vanessa Martucci Mariateresa Sanseviero Donatella Iorfida Concetta Malvaso Giovanni Cerimoniale Giuseppina Ragni Anna Lisa Grandinetti Loredana Arenare Silvia Bloise Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic Children preventive measures children infectious diseases drugs pediatric and healthcare expenditure |
title | Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic |
title_full | Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic |
title_fullStr | Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic |
title_full_unstemmed | Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic |
title_short | Change in Pediatric Health Care Spending and Drug Utilization during the COVID-19 Pandemic |
title_sort | change in pediatric health care spending and drug utilization during the covid 19 pandemic |
topic | preventive measures children infectious diseases drugs pediatric and healthcare expenditure |
url | https://www.mdpi.com/2227-9067/8/12/1183 |
work_keys_str_mv | AT riccardolubrano changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT emanueladelgiudice changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT alessiamarcellino changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT flaviaventriglia changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT annadilillo changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT enricadeluca changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT saveriomallardo changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT saraisoldi changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT vanessamartucci changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT mariateresasanseviero changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT donatellaiorfida changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT concettamalvaso changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT giovannicerimoniale changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT giuseppinaragni changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT annalisagrandinetti changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT loredanaarenare changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic AT silviabloise changeinpediatrichealthcarespendinganddrugutilizationduringthecovid19pandemic |